Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

HLS Therapeutics Inc. HLTRF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
23/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HLS Therapeutics Inc. (HLTRF) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

HLTRF Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to HLS Therapeutics Inc. in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

KHTRF
KHTRF
Knight Therapeutics Inc.
$5.49
+0.00%
 CPHRF
CPHRF
Cipher Pharmaceuticals Inc.
$14.15
+2.61%
 LOVFF
LOVFF
Cannara Biotech Inc.
$1.39
-3.46%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 CRRTF
CRRTF
Crescita Therapeutics Inc.
$0.54
+0.00%
 ANTCF
ANTCF
Aion Therapeutic Inc.
$0.00
+0.00%
 BINP
BINP
Bionoid Pharma Inc.
$0.03
0.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-5.09%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message